M460-2203 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-oxo-8-(thiomorpholin-4-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyrazin-2-yl]acetamide

M460-2203 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-oxo-8-(thiomorpholin-4-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyrazin-2-yl]acetamide
M460-2203 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-oxo-8-(thiomorpholin-4-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyrazin-2-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound M460-2203
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-oxo-8-(thiomorpholin-4-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyrazin-2-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M460-2203

Molecular Formula

C19H20N6O4S (C19 H20 N6 O4 S)

Compound Name

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-oxo-8-(thiomorpholin-4-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyrazin-2-yl]acetamide

IUPAC name

N-(23-dihydro-14-benzodioxin-6-yl)-2-[3-oxo-8-(thiomorpholin-4-yl)-2H3H-[124]triazolo[43-a]pyrazin-2-yl]acetamide

SMILES

O=C(CN1N=C(C(N2CCSCC2)=NC=C2)N2C1=O)Nc(cc1)cc2c1OCCO2

InChI

InChI=1S/C19H20N6O4S/c26-16(21-13-1-2-14-15(11-13)29-8-7-28-14)12-25-19(27)24-4-3-20-17(18(24)22-25)23-5-9-30-10-6-23/h1-4,11H,5-10,12H2,(H,21,26)

InChI Key

GXLSYEZBEVUWOR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27542814

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

428.47

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.052

Distribution Coefficient, logD

0.052

Water Solubility, LogSw

-2.42

Polar Surface Area

81.032

Acid Dissociation Constant (pKa)

12.03

Base Dissociation Constant (pKb)

1.14

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.80

M460-2203 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

SmartTM Library (51161 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Structure:
  • Mimetics
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with M460-2203 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M460-2203?
Check Price and Availability of M460-2203, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M460-2203 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M460-2203
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M460-2203
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M460-2203 available by request